[EN] METHODS OF USING FASN INHIBITORS<br/>[FR] PROCÉDÉS D'UTILISATION D'INHIBITEURS DE FASN
申请人:FORMA THERAPEUTICS INC
公开号:WO2017189613A1
公开(公告)日:2017-11-02
The present disclosure relates to methods of treating, preventing or ameliorating a TH17- or CSF1 -mediated disease or disorder such as cancer, immunological disorders, and obesity by administering to a patient in need thereof a therapeutically effective amount of a FASN inhibitor, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof.